Popping acidity pills? The quick fix may have a hidden cost

Ranitidine, a common anti-acidity drug, faces concerns. It may contain a contaminant linked to cancer risk. CDSCO directs monitoring of NDMA levels. Experts suggest reducing the drug’s shelf life. The US FDA had already withdrawn it. India continues monitoring. Other drugs like Pantoprazole also pose risks. Doctors advise caution and suggest alternatives.